Charlotte Fieuws

PhD Thesis
open access

Fishing for personalized ovarian cancer therapy

Charlotte Fieuws (UGent)

(2024)

Journal Article
A1
open access

Zebrafish avatars : toward functional precision medicine in low-grade serous ovarian cancer

Charlotte Fieuws (UGent) , Jan Willem Bek (UGent) , Bram Parton (UGent) , Elyne De Neef (UGent) , Olivier De Wever (UGent) , Milena Hoorne (UGent) , Marta F. Estrada, Jo Van Dorpe (UGent) , Hannelore Denys (UGent) , Koen Van de Vijver (UGent) , et al.

(2024) CANCERS. 16(10).

Add to list

Towards improved Parsortix® efficiency for circulating tumor cell enrichment in pancreatic cancer

Nele Vandenbussche (UGent) , Béatrice Lintermans (UGent) , Tijs Merckaert (UGent) , Charlotte Fieuws (UGent) , Kris Gevaert (UGent) and Kathleen Claes (UGent)

(2024) Belgian Society for Human Genetics (BeSHG) Annual Symposium 2024 : Single Cells : to care or not to care, Abstracts.

Add to list

Journal Article
A1
open access

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Charlotte Fieuws (UGent) , Joni Van der Meulen (UGent) , Kristiaan Proesmans (UGent) , Emiel De Jaeghere (UGent) , Siebe Loontiens (UGent) , Jo Van Dorpe (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) , Koen Van de Vijver (UGent) and Kathleen Claes (UGent)

(2024) NPJ PRECISION ONCOLOGY. 8(1).

Add to list

Conference Paper
C3
open access

Assessing recovery rates of mesenchymal and epithelial pancreatic tumor cells using the Parsortix system

Nele Vandenbussche (UGent) , Bram Parton (UGent) , Tijs Merckaert (UGent) , Charlotte Fieuws (UGent) , Luis Abreu de Carvalho (UGent) , Frederik Berrevoet (UGent) , Kris Gevaert (UGent) and Kathleen Claes (UGent)

(2023) 6th ACTC Advances in Circulating Tumor Cells 'Liquid Biopsy and Precision Oncology : Where do we stand now?' Book of Abstracts.

Add to list

Journal Article
A1
open access

A preclinical platform for assessing long-term drug efficacy exploiting mechanically tunable scaffolds colonized by a three-dimensional tumor microenvironment

Elly De Vlieghere (UGent) , Koen Van de Vijver (UGent) , Eva Blondeel (UGent) , Nathan Carpentier, Rouba Ghobeira (UGent) , Jarne Pauwels (UGent) , Sebastian Riemann (UGent) , Manon Minsart (UGent) , Charlotte Fieuws (UGent) , Johanna Mestach (UGent) , et al.

(2023) BIOMATERIALS RESEARCH. 27(1).

Add to list

Miscellaneous
open access

Atm deficient zebrafish model reveals conservation of the tumour suppressor function and a role in fertility

Jeroen Vierstraete, Charlotte Fieuws (UGent) , David Creytens (UGent) , Jo Van Dorpe (UGent) , Andy Willaert (UGent) , Anne Vral (UGent) and Kathleen Claes (UGent)

(2023) GENES & DISEASES. 10(2). p.381-384

Add to list

Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy

Jeroen Vierstraete, Charlotte Fieuws (UGent) , Andy Willaert (UGent) , Anne Vral (UGent) and Kathleen Claes (UGent)

(2021) DNA REPAIR. 97.

Add to list

Atm deficient zebrafish model reveals conservation of the tumour suppressor function

Jeroen Vierstraete, Charlotte Fieuws (UGent) , David Creytens (UGent) , Jo Van Dorpe (UGent) , Andy Willaert (UGent) , Anne Vral (UGent) and Kathleen Claes (UGent)

(2020) Belgian Society for Human Genetics, 20th Annual meeting, Abstracts.

Add to list

Isolation and engraftment of circulating tumor cells into zebrafish embryos to predict tumor response of ovarian cancer patients

Charlotte Fieuws (UGent) , Jeroen Vierstraete, Koen Van de Vijver (UGent) , Hannelore Denys (UGent) and Kathleen Claes (UGent)

(2020) CLINICAL CANCER RESEARCH. 26(11(suppl.)). p.82-82

Academic Bibliography

Charlotte Fieuws

Fishing for personalized ovarian cancer therapy

Zebrafish avatars : toward functional precision medicine in low-grade serous ovarian cancer

Towards improved Parsortix® efficiency for circulating tumor cell enrichment in pancreatic cancer

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Assessing recovery rates of mesenchymal and epithelial pancreatic tumor cells using the Parsortix system

A preclinical platform for assessing long-term drug efficacy exploiting mechanically tunable scaffolds colonized by a three-dimensional tumor microenvironment

Atm deficient zebrafish model reveals conservation of the tumour suppressor function and a role in fertility

Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy

Atm deficient zebrafish model reveals conservation of the tumour suppressor function

Isolation and engraftment of circulating tumor cells into zebrafish embryos to predict tumor response of ovarian cancer patients

Contents

Support

Contact